|
Volumn 145, Issue 3, 2001, Pages 472-475
|
Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study
|
Author keywords
Calcipotriol; Psoralen plus ultraviolet A therapy; Randomized controlled trial; Vitiligo
|
Indexed keywords
CALCIPOTRIOL;
METHOXSALEN;
PLACEBO;
PSORALEN;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG POTENTIATION;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION EXPOSURE;
SKIN DEFECT;
SKIN PIGMENTATION;
TISSUE DISTRIBUTION;
ULTRAVIOLET A RADIATION;
VITILIGO;
ADOLESCENT;
ADULT;
CALCITRIOL;
DERMATOLOGIC AGENTS;
DOUBLE-BLIND METHOD;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PUVA THERAPY;
RADIOTHERAPY DOSAGE;
VITILIGO;
|
EID: 0034795589
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2133.2001.04286.x Document Type: Article |
Times cited : (90)
|
References (12)
|